Xvivo Perfusion AB (publ) (0RKL.L)

373,00 +18,25 (+5,14%) Alla chiusura: 06:04PM BST

Xvivo Perfusion AB (publ)

Gemenskapens gata 9
Mölndal 431 53
Sweden
46 3 17 88 21 50
https://www.xvivogroup.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 148

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Christoffer Rosenblad	Chief Executive Officer	N/D	N/D	1975
Mr. Kristoffer Nordstrom	CFO & Investor Relation	N/D	N/D	1985
Ms. Lena Hagman B.Sc.	Chief Operating Officer	N/D	N/D	1965
Ms. Ylva Vihoj	Global Human Resources Director	N/D	N/D	1970
Dr. Magnus Nilsson Ph.D.	Senior Advisor	N/D	N/D	1956
Mr. Andreas Wallinder M.D., Ph.D.	Chief Medical Officer	N/D	N/D	1977
Mr. Johan Holmstrom	Chief Commercial Officer	N/D	N/D	1970

Gli importi risalgono al giorno e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in SEK.

Descrizione

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden, the United States, the Netherlands, Italy, North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. The company was incorporated in 1998 and is headquartered in Mölndal, Sweden.

Governance aziendale

L'ISS Governance QualityScore di Xvivo Perfusion AB (publ) al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.